Two-dimensional Nanomaterials for Cartilage Regeneration
Two-dimensional Nanomaterials for Cartilage Regeneration
批准号:
9317847
负责人:
Akhilesh K. Gaharwar
金额:
$6.98万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-01 至 2019-01-31
关键词:
AcidsAnimalsAreaArthritisBehaviorBioinformaticsBiologicalBlood VesselsCartilageCartilage MatrixCartilage injuryCellsChondrocytesChondrogenesisCollaborationsConsultationsDataDegenerative polyarthritisDevelopmentDiseaseEnsureExtracellular MatrixGenomicsGoalsGrowth FactorHigh PrevalenceHumanHydrogelsIn SituInjectableInsulin-Like Growth Factor IJointsLeadLettersMedicalMesenchymal Stem CellsMineralsMorbidity - disease rateNatural regenerationOutcomePainPathway interactionsPatientsPlayProceduresProductionProteinsPublishingRegenerative MedicineResearchSavingsSignal TransductionStem Cell ResearchTechnologyTherapeuticTherapeutic InterventionTissue EngineeringTransforming Growth FactorsTreatment EfficacyWorkbasecartilage degradationcartilage regenerationcartilaginousclinical applicationclinically relevanteffective therapygenome-wideinjuredmorphogensnanomaterialsnanoparticlenovelnovel therapeuticspreventresponsestem cell biologysymptom treatmenttranscriptome sequencingtransforming growth factor beta3treatment strategytwo-dimensionaluptakewhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Osteoarthritis (OA) is one of the most common forms of arthritis and characterized by progressive degradation
of cartilage. There is no cure for OA and is a largely unmet medical need for disease-modifying and
symptomatic treatment. Systemic delivery of morphogens and growth factors supporting cartilage matrix
synthesis, such as insulin like growth factor-1 (IGF-1) and/or transforming growth factor- β (TGF-β3), often
results in poor improvement due to the lack of vascularity within intra-articular spaces. Therefore, localized
intra-articular administration of growth factors targeting cartilage regeneration has emerged as a promising
strategy for therapeutic intervention in OA. The objective of this R03 proposal is to develop nanosilicates for
sustained delivery of OA-modifying therapeutics (IGF-1/ TGF-β3) to promote chondrocyte proliferation and
maturation. Our central hypothesis is that sustain release of OA-modifying therapeutics will promote
cartilaginous ECM production. The specific aims of this work are: (1) Understand the biological response of
nanosilicates with human cells, and (2) Investigate the efficacy of therapeutic loaded nanosilicates to induce chondrogenic
differentiation and production of cartilaginous ECM. The proposed research has tremendous transformative
potential in the areas of therapeutic delivery, cartilage regeneration, stem cell research and OA treatment.
Specifically, this project will introduce nanosilicates as a “plug-and-play” type of therapeutics delivery
platform for various tissue-engineering applications. In addition, the project will also result in a fundamental
shift in our understanding of mineral-induced cellular behavior, opening up an entirely new avenue in
regenerative medicine. Upon completion, we believe that our results will have a significant, positive impact on
regeneration of injured cartilage in patients suffering from osteoarthritis, for whom current treatment options
remain limited.
!
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mineralomics: Designing mineral based therapeutics to control and direct cell function
-
批准号:10402045
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2021
-
负责人:Akhilesh K. Gaharwar
-
依托单位:
Mineralomics: Designing mineral based therapeutics to control and direct cell function
-
批准号:10402044
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2021
-
负责人:Akhilesh K. Gaharwar
-
依托单位:
Mineralomics: Designing mineral based therapeutics to control and direct cell function
-
批准号:9350852
-
项目类别:
-
资助金额:$222.75万
-
财政年份:2017
-
负责人:Akhilesh K. Gaharwar
-
依托单位:
海外基金